Steroid-responsive demyelinating motor neuropathy with conduction block associated with hepatitis C infection and treatment with interferon alpha.
Couto
Marina
M
Conceição
Isabel
I
de Carvalho
Mamede
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects*; D003711:Demyelinating Diseases / Q000139:chemically induced* / Q000188:drug therapy; D005073:Evoked Potentials, Somatosensory; D005260:Female; D006526:Hepatitis C / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D009431:Neural Conduction; D018696:Neuroprotective Agents / Q000627:therapeutic use; D011129:Polyradiculoneuropathy / Q000139:chemically induced / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D018696:Neuroprotective Agents; D012254:Ribavirin; D011241:Prednisone; D008775:Methylprednisolone